Page last updated: 2024-08-21

dicarbethoxydihydrocollidine and kcc 009

dicarbethoxydihydrocollidine has been researched along with kcc 009 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, K; Khosla, C; Kosek, JC; Omary, MB; Siegel, M; Strnad, P; Toivola, DM1

Other Studies

1 other study(ies) available for dicarbethoxydihydrocollidine and kcc 009

ArticleYear
Pharmacologic transglutaminase inhibition attenuates drug-primed liver hypertrophy but not Mallory body formation.
    FEBS letters, 2006, Apr-17, Volume: 580, Issue:9

    Topics: Animals; Cell Size; Chemical and Drug Induced Liver Injury; Dicarbethoxydihydrocollidine; Enzyme Inhibitors; GTP-Binding Proteins; Hepatomegaly; Humans; Inclusion Bodies; Isoxazoles; Keratins; Liver Diseases; Mice; Mice, Inbred C3H; Protein Glutamine gamma Glutamyltransferase 2; Proteins; Transglutaminases

2006